Literature DB >> 24431817

A randomized clinical trial to compare the efficacy of submucosal aprotinin injection and intravenous dexamethasone in reducing pain and swelling after third molar surgery: a prospective study.

Gururaj Arakeri1, Kirthi Kumar Rai2, H R Shivakumar2, Bhushan Jayade2.   

Abstract

OBJECTIVE: The purpose of this study was to compare two different groups of drugs, aprotinin and dexamethasone for its efficacy in reducing post operative swelling and pain after third molar surgery.
METHODS: Fifty consecutive patients requiring surgical removal of single mandibular third molar (class II position B) under local anesthesia were randomly divided into two groups, each group consisting of 25 patients. One group was administered 8 mg dexamethasone through intravenous route pre-operatively. The other group received 1 ml of Aprotinin through submucosal route in operating area after the onset of local anesthesia. Swelling was assessed by measuring facial contours at baseline and at 1st, 3rd and 7th post-operative days. Pain was measured on the 1st, 3rd and 7th post-operative days using visual analog scale. Based on statistical analysis (paired t test and Wilcoxon's signed ranking test), the results showed statistically significant difference in post operative swelling and pain on 3rd postoperative day in dexamethasone group as compared to aprotinin group.
RESULTS: The results of present study showed a similar reduction in the severity of pain and swelling at the aprotinin and dexamethasone sites on 1st and 7th postoperative day. It was also noticed that the aprotinin promoted a greater reduction of swelling and pain on 3rd postoperative day.
CONCLUSION: It appeared that, benefits of aprotinin against the risks of dexamethasone and its efficacy in controlling pain and swelling after third molar surgery makes aprotinin to be a valuable alternative to dexamethasone.

Entities:  

Keywords:  Aprotinin; Dexamethasone; Pain; Submucosal injection; Swelling; Third molar

Year:  2012        PMID: 24431817      PMCID: PMC3589511          DOI: 10.1007/s12663-012-0364-8

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  21 in total

1.  An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation.

Authors:  G Asimakopoulos; R Thompson; S Nourshargh; E A Lidington; J C Mason; C P Ratnatunga; D O Haskard; K M Taylor; R C Landis
Journal:  J Thorac Cardiovasc Surg       Date:  2000-08       Impact factor: 5.209

2.  SUBJECTIVE AND OBJECTIVE MEASUREMENT OF RESPONSES TO THIRD MOLAR IMPACTION SURGERY.

Authors:  L SZMYD; I L SHANNON; W R HESTER; A STUMPF
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1964-02

3.  Effect of hyaluronidase on swelling and trismus after removal of impacted mandibular third molar teeth.

Authors:  P T FLEUCHAUS
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1956-05

4.  Glucocorticoid therapy.

Authors:  L Axelrod
Journal:  Medicine (Baltimore)       Date:  1976-01       Impact factor: 1.889

5.  An anaphylactic reaction after primary exposure to an aprotinin test dose in a child with a severe milk allergy.

Authors:  Roland N Kaddoum; Elie Joseph Chidiac; Maria M Zestos; Sankar D Rajan; Anis Baraka
Journal:  J Cardiothorac Vasc Anesth       Date:  2006-06-05       Impact factor: 2.628

6.  Steroid-induced myopathy and diabetes. Report of a case.

Authors:  D A Mason
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1972-04

7.  Use of ibuprofen and methylprednisolone for the prevention of pain and swelling after removal of impacted third molars.

Authors:  S Schultze-Mosgau; R Schmelzeisen; J C Frölich; H Schmele
Journal:  J Oral Maxillofac Surg       Date:  1995-01       Impact factor: 1.895

8.  An investigation into some of the factors concerned in the surgical removal of the impacted lower wisdom tooth, including a double blind trial of chymoral.

Authors:  I W Cameron
Journal:  Br J Oral Surg       Date:  1980-09

9.  A double blind clinical trial to assess the value of aprotinin in third molar surgery.

Authors:  P A Brennan; G T Gardiner; J McHugh
Journal:  Br J Oral Maxillofac Surg       Date:  1991-06       Impact factor: 1.651

10.  The use of intraoral dexamethasone after extraction of mandibular third molars.

Authors:  E J Messer; J J Keller
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1975-11
View more
  2 in total

1.  Oral dexamethasone decreases postoperative pain, swelling, and trismus more than diclofenac following third molar removal: a randomized controlled clinical trial.

Authors:  Carlos Alysson Aragão Lima; Vinícius Tatsumoto Favarini; Alexandre Machado Torres; Rogério Almeida da Silva; Fábio Ricardo Loureiro Sato
Journal:  Oral Maxillofac Surg       Date:  2017-06-08

2.  Efficacy of Various Routes of Dexamethasone Administration in Reducing Postoperative Sequelae Following Impacted Third Molar Surgery.

Authors:  G K Vivek; N Vaibhav; Akshay Shetty; Imran Mohammad; Nida Ahmed; Hemavathi Umeshappa
Journal:  Ann Maxillofac Surg       Date:  2020-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.